$246 Million is the total value of Endurant Capital Management LP's 55 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 106.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| INVACARE CORPnote 5.000%11/1 | $48,705,802 | -0.7% | 56,727,000 | 0.0% | 19.78% | +23.8% | ||
| LH | Sell | LABORATORY CORP AMER HLDGS | $21,410,784 | +7.5% | 90,924 | -6.5% | 8.70% | +34.0% |
| CI | Buy | CIGNA CORP NEW | $16,460,309 | +74.0% | 49,678 | +45.7% | 6.68% | +116.9% |
| MRK | New | MERCK & CO INC | $13,980,033 | – | 126,003 | +100.0% | 5.68% | – |
| CNC | New | CENTENE CORP DEL | $13,807,450 | – | 168,363 | +100.0% | 5.61% | – |
| ANTM | Buy | ELEVANCE HEALTH INC | $13,376,719 | +79.6% | 26,077 | +59.0% | 5.43% | +123.9% |
| ICLR | Sell | ICON PLC | $11,440,548 | -6.3% | 58,896 | -11.4% | 4.65% | +16.8% |
| AZN | Buy | ASTRAZENECA PLCsponsored adr | $9,588,276 | +73.0% | 141,420 | +40.0% | 3.89% | +115.7% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $8,730,106 | -29.2% | 84,357 | -42.0% | 3.54% | -11.7% |
| INVACARE CORPnote 5.000%11/1 | $8,457,651 | +0.2% | 10,097,000 | 0.0% | 3.44% | +25.0% | ||
| SBRA | New | SABRA HEALTH CARE REIT INC | $5,425,993 | – | 436,524 | +100.0% | 2.20% | – |
| AZYO | Buy | AZIYO BIOLOGICS INC | $5,353,062 | -34.8% | 1,259,544 | +10.5% | 2.17% | -18.7% |
| INSM | Buy | INSMED INC | $4,857,578 | +109.4% | 243,122 | +125.7% | 1.97% | +161.0% |
| ALBO | Buy | ALBIREO PHARMA INC | $4,693,886 | +40.5% | 217,209 | +25.8% | 1.91% | +75.2% |
| EHC | Sell | ENCOMPASS HEALTH CORP | $4,673,793 | +24.6% | 78,144 | -5.8% | 1.90% | +55.3% |
| SELB | Sell | SELECTA BIOSCIENCES INC | $4,268,708 | -33.9% | 3,777,618 | -4.1% | 1.73% | -17.6% |
| VKTX | New | VIKING THERAPEUTICS INC | $4,070,529 | – | 433,035 | +100.0% | 1.65% | – |
| ABC | New | AMERISOURCEBERGEN CORP | $3,485,544 | – | 21,034 | +100.0% | 1.42% | – |
| BNTX | New | BIONTECH SEsponsored ads | $3,254,366 | – | 21,664 | +100.0% | 1.32% | – |
| OCUL | Sell | OCULAR THERAPEUTIX INC | $2,989,708 | -32.3% | 1,063,953 | -0.0% | 1.21% | -15.6% |
| ADAP | Sell | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $2,530,525 | +31.6% | 1,733,236 | -3.1% | 1.03% | +64.2% |
| ZTS | Sell | ZOETIS INCcl a | $2,451,488 | -62.7% | 16,728 | -62.2% | 1.00% | -53.4% |
| STRO | Buy | SUTRO BIOPHARMA INC | $2,277,712 | +53.9% | 281,895 | +5.7% | 0.92% | +91.9% |
| QGEN | Sell | QIAGEN NV | $2,032,153 | -83.8% | 40,749 | -86.6% | 0.82% | -79.8% |
| THC | Sell | TENET HEALTHCARE CORP | $1,973,653 | -45.7% | 40,452 | -42.6% | 0.80% | -32.4% |
| BDX | Sell | BECTON DICKINSON & CO | $1,719,322 | -77.5% | 6,761 | -80.3% | 0.70% | -71.9% |
| BIO | Sell | BIO RAD LABS INCcl a | $1,636,968 | -43.8% | 3,893 | -44.3% | 0.66% | -29.9% |
| CTLT | Sell | CATALENT INC | $1,587,278 | -84.3% | 35,265 | -74.8% | 0.64% | -80.5% |
| HCA | New | HCA HEALTHCARE INC | $1,582,536 | – | 6,595 | +100.0% | 0.64% | – |
| SILK | New | SILK RD MED INC | $1,583,756 | – | 29,967 | +100.0% | 0.64% | – |
| PEAK | New | HEALTHPEAK PROPERTIES INC | $1,493,620 | – | 59,578 | +100.0% | 0.61% | – |
| TERN | New | TERNS PHARMACEUTICALS INC | $1,384,419 | – | 135,994 | +100.0% | 0.56% | – |
| CRL | New | CHARLES RIV LABS INTL INC | $1,363,618 | – | 6,258 | +100.0% | 0.55% | – |
| ARWR | New | ARROWHEAD PHARMACEUTICALS IN | $1,143,265 | – | 28,187 | +100.0% | 0.46% | – |
| BCAB | New | BIOATLA INC | $1,125,152 | – | 136,382 | +100.0% | 0.46% | – |
| TXG | New | 10X GENOMICS INC | $1,106,209 | – | 30,357 | +100.0% | 0.45% | – |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $1,092,239 | – | 4,596 | +100.0% | 0.44% | – |
| GRTS | New | GRITSTONE BIO INC | $976,126 | – | 282,935 | +100.0% | 0.40% | – |
| TMO | New | THERMO FISHER SCIENTIFIC INC | $875,046 | – | 1,589 | +100.0% | 0.36% | – |
| AXSM | New | AXSOME THERAPEUTICS INC | $868,792 | – | 11,264 | +100.0% | 0.35% | – |
| XRAY | New | DENTSPLY SIRONA INC | $703,282 | – | 22,088 | +100.0% | 0.29% | – |
| PTCT | New | PTC THERAPEUTICS INC | $682,709 | – | 17,886 | +100.0% | 0.28% | – |
| NTLA | New | INTELLIA THERAPEUTICS INC | $572,231 | – | 16,401 | +100.0% | 0.23% | – |
| BAX | Sell | BAXTER INTL INC | $561,078 | -95.7% | 11,008 | -95.5% | 0.23% | -94.7% |
| IGMS | New | IGM BIOSCIENCES INC | $515,743 | – | 30,320 | +100.0% | 0.21% | – |
| ATNM | New | ACTINIUM PHARMACEUTICALS INC | $485,768 | – | 45,612 | +100.0% | 0.20% | – |
| ETNB | New | 89BIO INC | $468,260 | – | 36,784 | +100.0% | 0.19% | – |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $451,485 | – | 70,655 | +100.0% | 0.18% | – |
| ITOS | New | ITEOS THERAPEUTICS INC | $410,931 | – | 21,041 | +100.0% | 0.17% | – |
| INBX | New | INHIBRX INC | $332,270 | – | 13,485 | +100.0% | 0.14% | – |
| MRVI | Sell | MARAVAI LIFESCIENCES HLDGS I | $307,064 | -47.1% | 21,458 | -5.5% | 0.12% | -33.9% |
| BDSX | Sell | BIODESIX INC | $286,189 | +73.4% | 124,430 | -4.4% | 0.12% | +114.8% |
| BMEA | New | BIOMEA FUSION INC | $285,617 | – | 33,881 | +100.0% | 0.12% | – |
| OYST | New | OYSTER PT PHARMA INC | $222,585 | – | 19,927 | +100.0% | 0.09% | – |
| ATNX | Buy | ATHENEX INC | $133,080 | -6.3% | 902,236 | +71.3% | 0.05% | +17.4% |
| MOR | Exit | MORPHOSYS AGsponsored ads | $0 | – | -68,290 | -100.0% | -0.11% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -9,211 | -100.0% | -0.14% | – |
| RLMD | Exit | RELMADA THERAPEUTICS INC | $0 | – | -14,145 | -100.0% | -0.17% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -7,915 | -100.0% | -0.18% | – |
| ABOS | Exit | ACUMEN PHARMACEUTICALS INC | $0 | – | -55,328 | -100.0% | -0.18% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCcl a | $0 | – | -24,352 | -100.0% | -0.20% | – |
| PCVX | Exit | VAXCYTE INC | $0 | – | -52,309 | -100.0% | -0.41% | – |
| OMI | Exit | OWENS & MINOR INC NEW | $0 | – | -55,914 | -100.0% | -0.44% | – |
| OPCH | Exit | OPTION CARE HEALTH INC | $0 | – | -43,457 | -100.0% | -0.45% | – |
| TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $0 | – | -179,226 | -100.0% | -0.47% | – |
| AVTR | Exit | AVANTOR INC | $0 | – | -75,948 | -100.0% | -0.48% | – |
| VCYT | Exit | VERACYTE INC | $0 | – | -108,751 | -100.0% | -0.59% | – |
| CANO | Exit | CANO HEALTH INC | $0 | – | -210,915 | -100.0% | -0.60% | – |
| GLPG | Exit | GALAPAGOS NVspon adr | $0 | – | -50,822 | -100.0% | -0.71% | – |
| RCUS | Exit | ARCUS BIOSCIENCES INC | $0 | – | -97,327 | -100.0% | -0.83% | – |
| MMSI | Exit | MERIT MED SYS INC | $0 | – | -51,218 | -100.0% | -0.94% | – |
| VTR | Exit | VENTAS INC | $0 | – | -85,683 | -100.0% | -1.12% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -16,168 | -100.0% | -1.79% | – |
| OHI | Exit | OMEGA HEALTHCARE INVS INC | $0 | – | -313,762 | -100.0% | -3.01% | – |
| BMY | Exit | BRISTOL-MYERS SQUIBB CO | $0 | – | -158,721 | -100.0% | -3.68% | – |
| LLY | Exit | LILLY ELI & CO | $0 | – | -38,311 | -100.0% | -4.04% | – |
| TAK | Exit | TAKEDA PHARMACEUTICAL CO LTDsponsored ads | $0 | – | -1,102,280 | -100.0% | -4.66% | – |
| HUM | Exit | HUMANA INC | $0 | – | -32,729 | -100.0% | -5.17% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
| ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
| BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
| MCKESSON CORP | 27 | Q1 2023 | 4.4% |
| CENCORA INC | 26 | Q3 2023 | 5.9% |
| HOLOGIC INC | 24 | Q3 2023 | 7.5% |
| JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
| ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
| DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
| Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-10 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-09-08 |
| 13F-HR | 2023-08-14 |
| 3/A | 2023-05-24 |
| 13F-HR | 2023-05-15 |
| 3 | 2023-05-15 |
| SC 13D | 2023-05-15 |
| SC 13G/A | 2023-03-21 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.